Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders.
Ontology highlight
ABSTRACT: Protein phosphatases act as key regulators of multiple important cellular processes and are attractive therapeutic targets for various diseases. Although extensive effort has been dedicated to phosphatase-targeted drug discovery, early expeditions for competitive phosphatase inhibitors were plagued by druggability issues, leading to the stigmatization of phosphatases as difficult targets. Despite challenges, persistent efforts have led to the identification of several drug-like, non-competitive modulators of some of these enzymes - including SH2 domain-containing protein tyrosine phosphatase 2, protein tyrosine phosphatase 1B, vascular endothelial protein tyrosine phosphatase and protein phosphatase 1 - reigniting interest in therapeutic targeting of phosphatases. Here, we discuss recent p
SUBMITTER: Stanford SM
PROVIDER: S-EPMC9872771 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA